Scholarship
University of Pavia Master's Degree in Industrial Nanobiotechnologies for Pharmaceuticals Scholarship
Fondazione Dompé ETS
Award
Not specified
Closing date
Closed
Location
Global
For
Individuals
About this opportunity
The Fondazione Dompé ETS offers scholarships for students pursuing a Master's Degree in Industrial Nanobiotechnologies for Pharmaceuticals at the University of Pavia in Italy. This two-year master's program focuses on the intersection of nanobiotechnology and pharmaceutical applications, providing students with advanced knowledge and skills in this specialized field. The scholarship program aims to support talented students in their academic pursuits within the pharmaceutical and biotechnology sectors.
The foundation will award four scholarships for the 2025/2026 academic year, with each scholarship valued at EUR 15,000 per year per student. This funding is designed to help cover tuition fees and living expenses during the two-year master's program. Students will have the opportunity to study at the University of Pavia, one of Italy's oldest and most prestigious universities, located in Pavia, Italy.
The scholarship provides financial support for the duration of the master's program, enabling students to focus on their studies in this cutting-edge field that combines industrial applications of nanotechnology with pharmaceutical development. The program prepares graduates for careers in pharmaceutical research, biotechnology companies, and related industries.
24 - 25 mo
4 awards
Renewable
(2yr)
Who can apply
Applicant Types
individual
Project Locations
🇮🇹 Italy
Region
Italy
How to apply
Stages
- 1 single_stage
External listing — not managed by a verified Grantory funder
External Application
This opportunity requires you to apply directly on the funder's website.
Apply on External SiteAI-Extracted Data
This opportunity was automatically extracted from an external source using AI. Details such as amounts, closing dates, and eligibility may be incomplete or inaccurate.
Always verify on the official source